Rita is a health economist at the University of York working mainly in economic evaluation. See https://tinyurl.com/y8ogvhjw for her academic profile.
Rita Faria covers how cost-effectiveness can inform prioritisation of patients for the treatment of hepatitis C, the cost-effectiveness of CAR-T therapy and requests for bad practice in biostatistics.
Every Monday our authors provide a round-up of some of the most recently published peer reviewed articles from the field. We don’t cover everything, or even what’s most important – just a few papers that have interested the author. Visit… Read More »Rita Faria’s journal round-up for 24th September 2018
Every Monday our authors provide a round-up of some of the most recently published peer reviewed articles from the field. We don’t cover everything, or even what’s most important – just a few papers that have interested the author. Visit… Read More »Rita Faria’s journal round-up for 13th August 2018
HESG Summer 2018 was hosted by the University of Bristol at the Mercure Bristol Holland House on 20th-22nd June. The organisers did a superb job… the hotel was super comfortable, the food & drink were excellent, and the discussions were… Read More »Meeting round-up: Health Economists’ Study Group (HESG) Summer 2018
Every Monday our authors provide a round-up of some of the most recently published peer reviewed articles from the field. We don’t cover everything, or even what’s most important – just a few papers that have interested the author. Visit… Read More »Rita Faria’s journal round-up for 18th June 2018